Literature DB >> 28504646

The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection.

Florian Ebner1, Vitaly Sedlyarov1, Saren Tasciyan2, Masa Ivin1, Franz Kratochvill1, Nina Gratz1, Lukas Kenner3,4,5, Andreas Villunger6,7, Michael Sixt2, Pavel Kovarik1.   

Abstract

Protective responses against pathogens require a rapid mobilization of resting neutrophils and the timely removal of activated ones. Neutrophils are exceptionally short-lived leukocytes, yet it remains unclear whether the lifespan of pathogen-engaged neutrophils is regulated differently from that in the circulating steady-state pool. Here, we have found that under homeostatic conditions, the mRNA-destabilizing protein tristetraprolin (TTP) regulates apoptosis and the numbers of activated infiltrating murine neutrophils but not neutrophil cellularity. Activated TTP-deficient neutrophils exhibited decreased apoptosis and enhanced accumulation at the infection site. In the context of myeloid-specific deletion of Ttp, the potentiation of neutrophil deployment protected mice against lethal soft tissue infection with Streptococcus pyogenes and prevented bacterial dissemination. Neutrophil transcriptome analysis revealed that decreased apoptosis of TTP-deficient neutrophils was specifically associated with elevated expression of myeloid cell leukemia 1 (Mcl1) but not other antiapoptotic B cell leukemia/lymphoma 2 (Bcl2) family members. Higher Mcl1 expression resulted from stabilization of Mcl1 mRNA in the absence of TTP. The low apoptosis rate of infiltrating TTP-deficient neutrophils was comparable to that of transgenic Mcl1-overexpressing neutrophils. Our study demonstrates that posttranscriptional gene regulation by TTP schedules the termination of the antimicrobial engagement of neutrophils. The balancing role of TTP comes at the cost of an increased risk of bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28504646      PMCID: PMC5451238          DOI: 10.1172/JCI80631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

Review 1.  Posttranscriptional regulation of cytokine expression.

Authors:  Pavel Kovarik; Florian Ebner; Vitaly Sedlyarov
Journal:  Cytokine       Date:  2015-11-14       Impact factor: 3.861

2.  Retardation of early-onset PMA-induced apoptosis in mouse neutrophils deficient in myeloperoxidase.

Authors:  T Tsurubuchi; Y Aratani; N Maeda; H Koyama
Journal:  J Leukoc Biol       Date:  2001-07       Impact factor: 4.962

3.  BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis.

Authors:  D A Moulding; C Akgul; M Derouet; M R White; S W Edwards
Journal:  J Leukoc Biol       Date:  2001-11       Impact factor: 4.962

4.  Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.

Authors:  Virginia Castiglia; Alessandra Piersigilli; Florian Ebner; Marton Janos; Oliver Goldmann; Ursula Damböck; Andrea Kröger; Sigfried Weiss; Sylvia Knapp; Amanda M Jamieson; Carsten Kirschning; Ulrich Kalinke; Birgit Strobl; Mathias Müller; Dagmar Stoiber; Stefan Lienenklaus; Pavel Kovarik
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

5.  Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

Authors:  Kirsteen J Campbell; Mary L Bath; Marian L Turner; Cassandra J Vandenberg; Philippe Bouillet; Donald Metcalf; Clare L Scott; Suzanne Cory
Journal:  Blood       Date:  2010-07-14       Impact factor: 22.113

6.  Isolation and surface labeling of murine polymorphonuclear neutrophils.

Authors:  S M Watt; A W Burgess; D Metcalf
Journal:  J Cell Physiol       Date:  1979-07       Impact factor: 6.384

7.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

Review 8.  Neutrophil kinetics in health and disease.

Authors:  Charlotte Summers; Sara M Rankin; Alison M Condliffe; Nanak Singh; A Michael Peters; Edwin R Chilvers
Journal:  Trends Immunol       Date:  2010-08       Impact factor: 16.687

9.  MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.

Authors:  Georg Stoecklin; Tiffany Stubbs; Nancy Kedersha; Stephen Wax; William F C Rigby; T Keith Blackwell; Paul Anderson
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

10.  Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin.

Authors:  Georg Stoecklin; Scott A Tenenbaum; Thomas Mayo; Sridar V Chittur; Ajish D George; Timothy E Baroni; Perry J Blackshear; Paul Anderson
Journal:  J Biol Chem       Date:  2008-02-06       Impact factor: 5.157

View more
  11 in total

Review 1.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

Review 2.  The role of RNA-binding protein tristetraprolin in cancer and immunity.

Authors:  Jian Guo; Huiheng Qu; Ye Chen; Jiazeng Xia
Journal:  Med Oncol       Date:  2017-11-09       Impact factor: 3.064

3.  MCPIP-1 Restricts Inflammation via Promoting Apoptosis of Neutrophils.

Authors:  Ewelina Dobosz; Marta Wadowska; Marta Kaminska; Mateusz Wilamowski; Mohsen Honarpisheh; Danuta Bryzek; Jan Potempa; Jolanta Jura; Maciej Lech; Joanna Koziel
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 4.  Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.

Authors:  Jia Cui; William J Placzek
Journal:  Int J Mol Sci       Date:  2018-01-20       Impact factor: 5.923

5.  Vasoactive intestinal peptide stabilizes intestinal immune homeostasis through maintaining interleukin-10 expression in regulatory B cells.

Authors:  Xiong Sun; Chuanyong Guo; Fang Zhao; Jianhuan Zhu; Yilu Xu; Zhi-Qiang Liu; Gui Yang; Yuan-Yi Zhang; Xia Gu; Liang Xiao; Zhanju Liu; Ping-Chang Yang
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

6.  Crucial Role of Nucleic Acid Sensing via Endosomal Toll-Like Receptors for the Defense of Streptococcus pyogenes in vitro and in vivo.

Authors:  Anna Hafner; Ulrike Kolbe; Isabel Freund; Virginia Castiglia; Pavel Kovarik; Tanja Poth; Franziska Herster; Markus A Weigand; Alexander N R Weber; Alexander H Dalpke; Tatjana Eigenbrod
Journal:  Front Immunol       Date:  2019-02-21       Impact factor: 7.561

7.  Tristetraprolin targets Nos2 expression in the colonic epithelium.

Authors:  Melanie A Eshelman; Stephen M Matthews; Emily M Schleicher; Rebecca M Fleeman; Yuka Imamura Kawasawa; Deborah J Stumpo; Perry J Blackshear; Walter A Koltun; Faoud T Ishmael; Gregory S Yochum
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 8.  Role of Tristetraprolin in the Resolution of Inflammation.

Authors:  Peter Rappl; Bernhard Brüne; Tobias Schmid
Journal:  Biology (Basel)       Date:  2021-01-19

9.  Context-Dependent IL-1 mRNA-Destabilization by TTP Prevents Dysregulation of Immune Homeostasis Under Steady State Conditions.

Authors:  Lucy Sneezum; Kevin Eislmayr; Helene Dworak; Vitaly Sedlyarov; Anita Le Heron; Florian Ebner; Irmgard Fischer; Yoichiro Iwakura; Pavel Kovarik
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 10.  Conceptual Advances in Control of Inflammation by the RNA-Binding Protein Tristetraprolin.

Authors:  Pavel Kovarik; Annika Bestehorn; Jeanne Fesselet
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.